lisocabtagene maraleucel
/L IH1 S AH0 K AE1 B T AH0 JH IY1 N M AA0 R AH0 L EH0 UW0 S AH0 L/N
- 1
Lisocabtagene maraleucel, sold under the brand name Breyanzi, is a cell-based gene therapy used to treat B-cell lymphomas, including follicular lymphoma.
Translate “lisocabtagene maraleucel” into another language
Choose a language below to open the translator with English selected as the source language.